Your Article Summary
Taro Receives Final FDA Approval for Lamotrigine Chewable Tablets ANDA
Taro Pharmaceuticals USA, 02/06/09
Taro Pharmaceutical Industries Ltd. reported that it has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Lamotrigine Tablets, 5 mg and 25 mg.
Today in Drug/Product Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
FDA Approves Gardasil to Prevent Genital Warts in Males. Agency Also Approves Bivalent HPV Vaccine for Girls, Young Women
American Family Physician, 10/27/09
Novartis receives FDA approval for Valturna®, a single-pill combination of valsartan and aliskiren, to treat high blood pressure
Novartis, 09/18/09
Salix Receives FDA Marketing Approval for Metozolv
Salix Pharmaceuticals, 09/09/09
Article Search
Sponsor


See Latest Articles


